Inventor
Tin-Yau Chan
Inventor
Edison, NJ, US
Overview
Patents· 32 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds26%
A61KPreparations for medical, dental or toiletry purposes16%
C07KPeptides9%
C07CAcyclic or carbocyclic compounds4%
C07HSugars4%
C40BCombinatorial chemistry4%
C12NMicroorganisms or enzymes1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
9,695,198'Factor IXa inhibitors'20178,987,242'Morpholinone compounds as factor IXA inhibitors'20158,871,929'Fused-imidazoyl compounds useful as antimicrobial agents'20148,765,757'3-heterocyclic substituted indole derivatives and methods of use thereof'20148,716,312'Inhibitors of diacylglycerol acyltransferase'20148,673,924'Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors'20148,642,582'Morpholinone compounds as factor IXa inhibitors'20148,614,229'Substituted indole derivatives and methods of use thereof'20138,609,676'4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors'20138,440,443'MEK1 polypeptides'2013RE043298'Peptides as NS3-serine protease inhibitors of hepatitis C virus'20128,148,363'Heterocyclic compounds as factor IXA inhibitors'20128,143,305'2,3-substituted indole derivatives for treating viral infections'20127,884,080'Azetidinone derivatives and methods of use thereof'20117,807,683'N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors'20107,700,601'Substituted indazoles of formula 1.0 that are kinase inhibitors'20107,652,020'Compounds for the treatment of inflammatory disorders'20107,595,299'Peptides as NS3-serine protease inhibitors of hepatitis C virus'20097,528,132'Kinase inhibitors'20097,514,442'Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors'20097,452,891'MCH antagonists and their use in the treatment of obesity'20087,244,721'Peptides as NS3-serine protease inhibitors of hepatitis C virus'20077,169,760'Peptides as NS3-serine protease inhibitors of hepatitis C virus'20077,161,003'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'20077,119,200'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'20067,067,661'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'20067,012,066'Peptides as NS3-serine protease inhibitors of hepatitis C virus'20066,914,122'Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties'20056,900,329'MCH antagonists and their use in the treatment of obesity'20056,274,716'Combinatorial library of moenomycin analogs and methods of producing same'20016,207,820'Combinatorial library of moenomycin analogs and methods of producing same'20016,114,309'Combinatorial library of moenomycin analogs and methods of producing same'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2017Based in Edison, NJ, US· patent location history
2005–2012Patents assigned to SCHERING CORP (12)· patent assignee history
2006–2012Patents assigned to DENDREON CORP (5)· patent assignee history
2012–2017Patents assigned to CHAN TIN-YAU (13)· patent assignee history
2012–2017Patents assigned to CHACKALAMANNIL SAMUEL (5)· patent assignee history
2013–2017Patents assigned to MERCK SHARP & DOHME (10)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHAN TIN-YAUself | 13 | 2012–2017 |
| SCHERING CORP | 12 | 2005–2012 |
| MERCK SHARP & DOHME | 10 | 2013–2017 |
| CHACKALAMANNIL SAMUEL | 5 | 2012–2017 |
| DENDREON CORP | 5 | 2006–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Edison, New Jersey, US | 32 | 2000–2017 |